Resolution of coronavirus disease 2019 (COVID-19)

References

• El-Sahly HM, Atmar RL, Glezen WP, et al. Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clinl Infect Dis. 2000;31(1):96–100.
   PubMed Web of Science ®Google Scholar
• Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967–1976.
   PubMed Web of Science ®Google Scholar
• Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020 Jan 30;323(8):709.
   PubMed Web of Science ®Google Scholar
• Li X, Wang W, Zhao X, et al. Transmission dynamics and evolutionary history of 2019-nCoV. J Med Virol. 2020 May;92(5):501–511.
   PubMed Web of Science ®Google Scholar
• Monchatre-Leroy E, Boué F, Boucher J-M, et al. Identification of alpha and beta coronavirus in wildlife species in France: bats, rodents, rabbits, and hedgehogs. Viruses. 2017;9(12):364.
   PubMed Web of Science ®Google Scholar
• Li B, Si H-R, Zhu Y, et al. Discovery of bat coronaviruses through surveillance and probe capture-based next-generation sequencing. Msphere. 2020;5:1.
   Web of Science ®Google Scholar
• Ji W, Wang W, Zhao X, et al. Cross‐species transmission of the newly identified coronavirus 2019‐nCoV. J Med Virol. 2020;92(4):433–440.
   PubMed Web of Science ®Google Scholar
• Kirby T. Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities. Lancet Respir Med. 2020;8(6):547–548.
   Web of Science ®Google Scholar
• Khunti K, Singh AK, Pareek M, et al. Is ethnicity linked to incidence or outcomes of covid-19? Br Med J Publ Group. 2020. DOI: 10.1136/bmj.m1548.
   Google Scholar
• Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020;25(4):2000058.
   PubMedGoogle Scholar
• Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971.
   PubMed Web of Science ®Google Scholar
• Zhang W, Du R-H, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389.
   PubMed Web of Science ®Google Scholar
• To KK-W, Tsang OT-Y, Leung W-S, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020; (5): 565–574. DOI: 10.1016/S1473-3099(20)30196-1.
   Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224): 565–574.
   PubMed Web of Science ®Google Scholar
• Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94(7):7.
   Web of Science ®Google Scholar
• Sun J, He W-T, Wang L, et al., COVID-19: epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med. 2020;26(5): 483–495.
   PubMed Web of Science ®Google Scholar
• Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.
   PubMed Web of Science ®Google Scholar
• Neurath MF. Covid-19 and immunomodulation in IBD. Gut. 2020;69(7):1335–1342. gutjnl–2020–321269.
   Web of Science ®Google Scholar
• Masters PS. The molecular biology of coronaviruses. advances in virus research. Vol. 66. Academic Press; 2006. p. 193–292.
   Google Scholar
• Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444–1448.
   PubMed Web of Science ®Google Scholar
• Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020 March 13;7(1):11.
   PubMed Web of Science ®Google Scholar
• Ryu S, Chun BC; of Epidemiology KS. An interim review of the epidemiological characteristics of 2019 novel coronavirus. Epidemiol Health. 2020;42.
   Web of Science ®Google Scholar
• Zhang -J-J, Dong X, Cao -Y-Y, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75(7):1730–1741.
   Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626.
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Fett C, Mack M, et al. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol. 2017;198(10):4046–4053.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Robinson DP, Lorenzo ME, Jian W, et al. Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS Pathog. 2011 Jul;7(7):e1002149.
   PubMed Web of Science ®Google Scholar
• Jin J-M, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. medRxiv. 2020. Front Public Health. 2020;8:152.
   Google Scholar
• Organization WH, Organization WH Report of the who-china joint mission on coronavirus disease 2019 (covid-19). Geneva; 2020.
   Google Scholar
• Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427.
   PubMed Web of Science ®Google Scholar
• Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. J Med Virol. 2020;92(4):441–447.
   PubMed Web of Science ®Google Scholar
• Babyn PS, Chu WC, Tsou IY, et al. Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatr Radiol. 2004;34(1):47–58.
   PubMed Web of Science ®Google Scholar
• Qiu H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20(6):689–696.
   Web of Science ®Google Scholar
• Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. 2015;p. 1–23.
   Google Scholar
• Wu H-S, Chiu S-C, Tseng T-C, et al. Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. Emerg Infect Dis. 2004;10(2):304–310.
   PubMed Web of Science ®Google Scholar
• Haveri A, Smura T, Kuivanen S, et al. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill. 2020;25(11):2000266.
   Google Scholar
• Patel R, Babady E, Theel ES, et al. Report from the American Society for Microbiology COVID-19 international summit, 23 march 2020: value of diagnostic testing for SARS-CoV-2/COVID-19. mBio. 2020 Mar 26;11(2). DOI:10.1128/mBio.00722-20.
   Web of Science ®Google Scholar
• Zaki AM, Van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820.
   PubMed Web of Science ®Google Scholar
• Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020 Dec;9(1):747–756.
   PubMed Web of Science ®Google Scholar
• Folz RJ, Elkordy MA. Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer. Chest. 1999;115(3):901–905.
   PubMed Web of Science ®Google Scholar
• Association CM. Radiological diagnosis of new coronavirus infected pneumonitis: expert recommendation from the Chinese Society of Radiology. Chin J Radiol. 2020;54:E001–E001.
   Google Scholar
• Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514–523.
   PubMed Web of Science ®Google Scholar
• Committee GOoNH. Office of state administration of traditional Chinese Medicine. Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 3). 2020. 2020.
   Google Scholar
• Kanne JP Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiological Society of North America; 2020.
   Google Scholar
• Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295(3):200463.
   PubMed Web of Science ®Google Scholar
• Bruning AHL, Aatola H, Toivola H, et al. Rapid detection and monitoring of human coronavirus infections. New Microbes New Infect. 2018 Jul;24:52–55.
   PubMedGoogle Scholar
• Himoto Y, Sakata A, Kirita M, et al. Diagnostic performance of chest CT to differentiate COVID-19 pneumonia in non-high-epidemic area in Japan. Jpn J Radiol. 2020 Mar 30;38(5):400–406.
   PubMed Web of Science ®Google Scholar
• Wu Y-C, Chen C-S, Chan Y-J. The outbreak of COVID-19: an overview. J Chin Med Assoc. 2020;83(3):217.
   PubMed Web of Science ®Google Scholar
• Radbruch L, Knaul FM, de Lima L, et al. The key role of palliative care in response to the COVID-19 tsunami of suffering. Lancet. 2020;395(10235):1467–1469.
   PubMed Web of Science ®Google Scholar
• Tanja F-S, Nancy P, Keller N, et al. Conservative management of Covid-19 patients–emergency palliative care in action. J Pain Sympt Manage. 2020. DOI:10.1016/j.jpainsymman.2020.03.030.
   Google Scholar
• Bajwah S, Wilcock A, Towers R, et al. Managing the supportive care needs of those affected by COVID-19. Eur Respir Soc. 2020;55(4):2000815.
   PubMed Web of Science ®Google Scholar
• Coleman CM, Frieman MB. Coronaviruses: important emerging human pathogens. J Virol. 2014;88(10):5209–5212.
   PubMed Web of Science ®Google Scholar
• Jing Y, Run-Qian L, Hao-Ran W, et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020;26(6):367–373.
   Web of Science ®Google Scholar
• Dhama K, Sharun K, Tiwari R, et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines Immunother. 2020 Jun 2;16(6):1232–1238.
   Web of Science ®Google Scholar
• Al-Tawfiq JA, Al-Homoud AH, Memish ZA. Remdesivir as a possible therapeutic option for the COVID-19. Travel Med Infect Dis. 2020;34:101615.
   Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271.
   PubMed Web of Science ®Google Scholar
• Dorward J, Gbinigie K. Lopinavir/ritonavir. A Rapid Review of Effectiveness in COVID. 2020;19.
   Google Scholar
• Paranjpe I, Fuster V, Lala A, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020 May 5;76(1):122–124.
   Web of Science ®Google Scholar
• Paranjpe I, Fuster V, Lala A, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(1):122–124.
   Web of Science ®Google Scholar
• An audio transcript of the news briefing held by the State Council of China . The National Health Commission of the People’s Republic of China. 2020.
   Google Scholar
• US Food and Drug Administration. FDA news release coronavirus (COVID-19) update. Travel medicine and infectious disease. 2020.
   Google Scholar
• Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73.
   Web of Science ®Google Scholar
• Bhowmik D, Nandi R, Kumar D Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. 2020.
   Google Scholar
• Rosales-Mendoza S, Márquez-Escobar VA, González-Ortega O, et al. What does plant-based vaccine technology offer to the fight against COVID-19? Vaccines (Basel). 2020;8(2):183.
   PubMed Web of Science ®Google Scholar
• Carradori S. Are there any Therapeutic options currently available for Wuhan coronavirus? Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):85–87.
   PubMedGoogle Scholar
• Choi J, Kim MG, Oh YK, et al. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review. Expert Opin Ther Patents. 2017 Jun;27(6):721–731.
   PubMed Web of Science ®Google Scholar
• Xia S, Liu M, Wang C, et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res. 2020 Apr;30(4):343–355.
   PubMed Web of Science ®Google Scholar
• Li H, Wang Y, Xu J, et al. Potential antiviral therapeutics for 2019 Novel Coronavirus. Zhonghua Jie He He Hu Xi Za Zhi= Zhonghua Jiehe He Huxi Zazhi= Chinese Journal of Tuberculosis and Respiratory Diseases. 2020;43:E002–E002.
   PubMedGoogle Scholar
• Mantlo E, Bukreyeva N, Maruyama J, et al. Antiviral activities of type i interferons to SARS-CoV-2 infection. Antiviral Res. 2020;179:104811.
   PubMed Web of Science ®Google Scholar
• Sallard E, Lescure F-X, Yazdanpanah Y, et al. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020;178:104791.
   PubMed Web of Science ®Google Scholar
• Wheeler TM, Leger AJ, Pandey SK, et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature. 2012;488(7409):111–115.
   PubMed Web of Science ®Google Scholar
• Orr R. Technology evaluation: fomivirsen, Isis pharmaceuticals Inc/CIBA vision. Curr Opin Mol Ther. 2001;3(3):288–294.
   PubMed Web of Science ®Google Scholar
• Group VS. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Am J Ophthalmol. 2002;133(4):467–474.
   PubMed Web of Science ®Google Scholar
• Crooke ST, Witztum JL, Bennett CF, et al. RNA-targeted therapeutics. Cell Metab. 2018;27(4):714–739.
   PubMed Web of Science ®Google Scholar
• Rossi JJ, Rossi D Oligonucleotides and the COVID-19 Pandemic: A Perspective. nucleic acid therapeutics. 2020.
   Google Scholar
• Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590.
   Web of Science ®Google Scholar
• McCreary EK, Pogue JM, editors. Coronavirus disease 2019 treatment: a review of early and emerging options. Open forum infectious diseases. Oxford University Press US; 2020. DOI:10.1093/ofid/ofaa105.
   Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8.
   Web of Science ®Google Scholar
• Wu C, Liu Y, Yang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sinica B. 2020;10(5):766–788.
   Web of Science ®Google Scholar
• Mahase E. Covid-19: low dose steroid cuts death in ventilated patients by one third, trial finds. British Medical Journal Publishing Group; 2020.
   Google Scholar
• Horby P, Lim WS, Emberson J, et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv. 2020.
   Google Scholar